Cancer-induced, immune-mediated ocular degenerations.
The means whereby vision can be lost from a disease located distant from the eye include autoimmunity, with sensitization resulting from extraocular stimuli, a process illustrated here by the immunologic confusion caused by cancers. The uncontrolled proliferation of malignancies commonly involves the expression of components of the central nervous system, but a damaging loss of tolerance is rare. When autoimmunity does develop, organ-specific antigens are more often involved than the more generalized and widely disseminated common neuronal components. A focus upon a single antigen is typical of the immune-mediated paraneoplasia, a collection of syndromes identified by unusual antibody reactions. This review provides an outline of the immunologic trail that led to the recognition of autoimmunity in paraneoplastic ocular degenerations, how specific antibody reactions aid in diagnosis, and the possibility of including antibodies in modes for sight-saving intervention. 'Those who do not know history are destined to repeat it'.
Thirkill
Charles E
CE
CAR Reference Laboratory, Research One, U.C. Davis Medical Center, Sacramento, CA 95817, USA. cethirkill@ucdavis.edu
D000818:Animals; D015551:Autoimmunity / Q000276:immunology; D018450:Disease Progression; D006801:Humans; D009902:Optic Neuritis / Q000209:etiology / Q000276:immunology*; D010257:Paraneoplastic Syndromes / Q000150:complications / Q000276:immunology*; D012162:Retinal Degeneration / Q000209:etiology / Q000276:immunology*; D012307:Risk Factors